Gilead Sciences, Inc (NASDAQ:GILD) Shares Sold by Bahl & Gaynor Inc themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) announced a quarterly dividend on Thursday, April 25th, Zacks reports. Investors of record on Friday, June 14th will be paid a dividend of 0.77 per share by the biopharmaceutical company on Thursday, June 27th. This represents a $3.08 dividend on an annualized basis and a yield of […]
Meritage Portfolio Management cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 65,558 shares of the biopharmaceutical company’s stock after selling 342 shares during the quarter. Meritage Portfolio Management’s holdings […]
Gilead Sciences (NASDAQ:GILD – Get Free Report)‘s stock had its “hold” rating reiterated by Needham & Company LLC in a research note issued on Friday, Benzinga reports. Other equities research analysts have also issued research reports about the stock. Truist Financial lowered shares of Gilead Sciences from a “buy” rating to a “hold” rating and […]
Gilead Sciences (NASDAQ:GILD) Given New $74 00 Price Target at Royal Bank of Canada theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.